ACCP Financials 07/16/2014 20:22:27 Access Pharma

ACCP Financials 07/16/2014 20:22:27
Access Pharmaceuticals, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 2,042 4,404 1,839 481
Cost of Revenue 125 267 148 140
Gross Profit 1,917 4,137 1,691 341
Operating Expenses
Research and Development 884 2,010 3,579 3,349
Sales, General and Admin. 4,834 6,024 5,755 4,511
Non-Recurring Items - - - -
Other 3 419 233 238
Operating Income (3,804) (4,316) (7,876) (7,757)
Income From Continuing Operations
Add'l Income/Expense Items 8,532 (5,608) 5,361 827
Earnings Before Interest and Tax 4,728 (9,924) (2,515) (6,930)
Interest Expense 279 608 - 607
Earnings Before Tax 4,449 (10,532) (2,515) (7,537)
Income Tax - - 17 -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations 4,449 (10,532) (2,532) (7,537)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 4,449 (10,532) (2,532) (7,537)
Preferred Stock and Other Adjustments (2,898) (1,999) (1,774) (1,791)
Net Income Applicable to Common Shareholders 1,551 (12,531) (4,306) (9,328)